title: Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial.
authors.forename: Alfredo E
authors.initials: AE
authors.lastname: Rodriguez
authors.forename: Juan
authors.initials: J
authors.lastname: Mieres
authors.forename: Carlos
authors.initials: C
authors.lastname: Fernandez-Pereira
authors.forename: Cesar F
authors.initials: CF
authors.lastname: Vigo
authors.forename: Maximo
authors.initials: M
authors.lastname: Rodriguez-Alemparte
authors.forename: Daniel
authors.initials: D
authors.lastname: Berrocal
authors.forename: Liliana
authors.initials: L
authors.lastname: Grinfeld
authors.forename: Igor
authors.initials: I
authors.lastname: Palacios
mesh_terms: D000368:Aged; D023903:Coronary Restenosis / Q000209:etiology; D003331:Coronary Vessels; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology*
chemical_list: D017239:Paclitaxel; D020123:Sirolimus